Rynse | $5,000,000 | (Jan 30, 2025)
Canvas | $10,000,000 | (Jan 30, 2025)
Leap(INDIA) | $65,000,000 | (Jan 30, 2025)
Certified by Founder
Lodge
PetDx
start up
United States
- San Diego
- 09/12/2021
- Series B
- $62,000,000
PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatic algorithms empowering veterinarians to provide superior care to canine patients.
- Industry Biotechnology Research
- Website https://petdx.com/
- LinkedIn https://www.linkedin.com/company/petdx/
Related People
Daniel S. GrosuFounder
United States -
San Diego, California,
Making the world a better place for pets... and their humans.
Intryc (YC S24) | $3,100,000 | (Jan 30, 2025)
D3 | $25,000,000 | (Jan 30, 2025)
Conifers.ai | $25,000,000 | (Jan 30, 2025)
Delfina | $17,000,000 | (Jan 30, 2025)
MSTRO | $1,500,000 | (Jan 30, 2025)
The Helper Bees | $35,000,000 | (Jan 29, 2025)
Applied Labs | $4,200,000 | (Jan 29, 2025)
Atalanta Therapeutics | $75,000,000 | (Jan 29, 2025)
Naboo | $20,828,000 | (Jan 29, 2025)